New from NICE

Technology appraisal. Apixaban for the prevention of stroke and systemic embolism in people with nonvalvular atrial fibrillation with one or more risk factor for stroke or systemic embolism.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa